The epithelium, which is the origin of over 85% of breast malignancies, is physically separated from the stroma by the myoepithelial cell layer and basement membrane [@B1]. The epithelium is normally devoid of lymphatic ducts and blood vessels, and thus, totally relies on the stroma for its essential needs. The epithelial cells are normally held in place by intercellular junctions and surface adhesion molecules [@B2]. Due to these structural relationships, the disruption of these structures is a pre-requisite for tumor invasion into the stroma, which is believed to be a multistage process, progressing sequentially from normal to hyperplasia, to *in situ*, and to invasive stages [@B3]. Progression from an *in situ* to invasive stage is believed to be triggered by overproduction of proteolytic enzymes primarily by cancer cells [@B4],[@B5]. Tumor metastasis is also believed to be a multistage process, requiring the tumor cells to dissociate from the primary site, enter the circulation, migrate to distant sites, and proliferate (6). The mechanism of tumor metastasis, however, remains as a subject of debate.

Recently, there has been a great deal of interest in the role of immune cells in tumor invasion and metastasis, and several models, including paracrine loop signaling, tumor-educated macrophages, immune cell-based mediation, and cancer cell-leukocyte fusion [@B7]-[@B11], have been proposed to explain how immune cells could facilitate metastasis. Collectively, these models suggest that immune cells facilitate tumor invasion and metastasis through the following mechanisms: (1) macrophages enhance tumor cell migration through secretion of chemotactic and chemokinetic factors, which promote angiogenesis and fibrillogenesis, allowing tumor cells track along collagen fibers to blood vessels [@B7],[@B8], (2) T-lymphocytes indirectly promote invasion and metastasis by directly regulating the phenotype and effector function of tumor associated CD11b(+)Gr1(-)F4/80(+) macrophages [@B9],[@B10], and (3) macrophages ingest tumor cells, resulting in the fusion of genetic materials of two cell types that creates a hybrid phenotype [@B11]. Each of these models is supported by laboratory findings or clinical data, suggesting that metastasis is likely to occur through multiple mechanisms. However, it is not currently possible to discern the mechanistic origin of a given metastatic lesion. In addition, two critical issues remain: (1) how metastasis-initiating cells are disseminated from their primary sites, and (2) how disseminated tumor cells escape from the immune-surveillance during their journey to new sites. More importantly, the specific molecule and unique morphological feature of pending or early metastatic lesions remain elusive, making it difficult for early detection and intervention of tumor metastasis.

Since the loss of the myoepithelial cell layer is the primary pathological criterion for the diagnosis of invasive breast lesions (1), our recent studies have attempted to identify early alterations of this layer. Of over 8,000 ducts and acini examined from over 400 cases, our study revealed that about 10% of patients harbored a high frequency of focal disruptions in the myoepithelial cell layers of ducts or acini with pre-invasive tumors. Ducts and acini with a focally disrupted myoepithelial cell layer had a significantly higher frequency of leukocyte infiltration than their counterparts with non-disrupted layers, 97.4% versus 22.2%, and a vast majority of infiltrated leukocytes were located at or near the disruptions [@B12]-[@B15]. Epithelial cells overlaying disruptions had a significantly higher frequency of ER negativity, elevated proliferation, aberrant DNA structural alterations, and expression of invasion and metastasis-related genes than their counterparts within the same duct but distant from disruptions [@B12]-[@B15]. Our findings have led to a novel hypothesis that breast tumor invasion is triggered by focal myoepithelial cell degeneration induced leukocyte (mainly CD8 (+) and CD 4(+) lymphocytes) infiltration that results in focal disruptions in the myoepithelial cell layer, which selectively favor monoclonal proliferation and stromal invasion of tumor progenitors overlying these disruptions [@B16].

Our more recent studies have further shown that aberrant leukocyte infiltration may also represent a trigger factor for tumor metastasis through the pathways depicted in Fig [1](#F1){ref-type="fig"}.

This hypothesis fundamentally differs from existing theories of tumor metastasis [@B7]-[@B11]. Based on this hypothesis, leukocytes (mainly T-lymphocytes) could directly trigger tumor invasion and metastasis through three correlated pathways: (1) physical disruptions of the inter-cellular junctions and surface adhesion molecules, causing tumor cell dissociation from primary sites, (2) formation of tight junctions with the plasma membrane of tumor cells, allowing leukocytes to physically drag their partners to distant sites during their migration, and (3) formation of tight junctions with the plasma membranes of mitotic cells, interfering with the cell division process. Our recent studies with confocal microscope have confirmed the tight plasma membrane junctions between leukocytes and tumor cells [@B17]. The mechanism for the formation of tight membrane junctions between leukocytes and tumor cells is unknown, but may involve the formation of microvesicles by the tumor cells. Microvesicles released from the membranes of tumor cells contain proteins that may act as self-epitopes [@B18],[@B19], which stimulate production of corresponding auto-antibodies, or activate a subset of leukocytes. Prior to their release, these microvesicles are small particles embedded within the tumor cell plasma membrane, and could potentially function as receptors for the leukocytes, leading to the formation of TLCs [@B18], [@B19]. It is also possible that these dissociated tumor cells may belong to a population of tumor stem cells, which has unique expression of plasma membrane-related proteins that function as receptors for the leukocytes.

This hypothesis presents a unique explanation for the initial dissemination of tumor cells from their primary sites and their subsequent journey to new sites. If confirmed, it could have several significant implications. Scientifically, it could lead to a new direction to acquire more effective approaches for detection, intervention, and prevention of invasion and metastasis. Clinically, it may have a number of beneficial applications, including: (1) double immunostaining to assess the extent of focal myoepithelial cell layer disruptions and leukocyte infiltration of *in situ*tumors may facilitate differentiation between those at high or low risk to progress, (2) a quantitative assessment of myoepithelial cell degeneration-related molecules, or the number of leukocyte subtypes preferentially associated with degeneration-related changes in blood samples may be used as a screen tool to indentify the individuals at a greater risk to develop invasive or metastatic lesions, and (3) the development of therapeutic agents to target the specific leukocyte subtypes that are physically associated with epithelial cells may provide a more effective means to treat and prevent tumor invasion and metastasis. In addition, this hypothesis may be applicable to all epithelium-derived tumors, as leukocytes are widely distributed in abundance in almost all human tissues.
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